Results 101 to 110 of about 11,929 (196)

DNA vaccines elicit durable protective immunity against individual or simultaneous infections with Lassa and Ebola viruses in guinea pigs

open access: yesHuman Vaccines & Immunotherapeutics, 2017
We previously developed optimized DNA vaccines against both Lassa fever and Ebola hemorrhagic fever viruses and demonstrated that they were protective individually in guinea pig and nonhuman primate models.
Kathleen A. Cashman   +8 more
doaj   +1 more source

Crimean-Congo hemorrhagic fever: A global perspective

open access: yes, 2007
Crimean-Congo hemorrhagic fever (CCHF) is a tick-borne disease associated with severe hemorrhagic manifestations. CCHF has been referred to as the Asian Ebola. However, in fact, the disease is one of the most widely distributed tick-borne diseases in the

core   +1 more source

Learning from other countries: an on-call facility for health care policy.

open access: yes, 2008
Recognizing that robust information on health systems in other countries can provide valuable lessons for the English National Health Service, the Department of Health commissioned an academic team to provide an 'On-call Facility for International ...
Sarah Thomson   +7 more
core   +1 more source

Measuring the health of nations: updating an earlier analysis.

open access: yes, 2008
We compared trends in deaths considered amenable to health care before age seventy-five between 1997-98 and 2002-03 in the United States and in eighteen other industrialized countries.
Nolte, Ellen, McKee, C Martin
core   +1 more source

Clinical Manifestations and Case Management of Ebola Haemorrhagic Fever caused by a newly identified virus strain, Bundibugyo, Uganda, 2007-2008

open access: yes, 2012
A confirmed Ebola haemorrhagic fever (EHF) outbreak in Bundibugyo, Uganda, November 2007-February 2008, was caused by a putative new species (Bundibugyo ebolavirus). It included 93 putative cases, 56 laboratory-confirmed cases, and 37 deaths (CFR = 25%).
Yoti Zabulon   +47 more
core   +1 more source

Factors Associated with Marburg Hemorrhagic Fever:

open access: yes, 2010
Background. Reliable on-site polymerase chain reaction (PCR) testing for Marburg hemorrhagic fever (MHF) is not always available. Therefore, clinicians triage patients on the basis of presenting symptoms and contact history.
Strong, James E   +24 more
core   +1 more source

Treatment of Marburg and Ebola hemorrhagic fevers: A strategy for testing new drugs and vaccines under outbreak conditions.

open access: yes, 2008
The filoviruses, Marburg and Ebola, have the dubious distinction of being associated with some of the highest case-fatality rates of any known infectious disease-approaching 90% in many outbreaks.
Bausch, D G   +7 more
core   +1 more source

Location of Ebola hemorrhagic fever (red circles) and Marburg hemorrhagic fever (green squares) outbreaks.

open access: yes, 2013
Location of Ebola hemorrhagic fever (red circles) and Marburg hemorrhagic fever (green squares) outbreaks.
Adam MacNeil (200514)   +1 more
core   +1 more source

Crimean-congo hemorrhagic fever virus in ticks from imported livestock, Egypt. [PDF]

open access: yes, 2012
Alia Zayed   +13 more
core   +1 more source

Home - About - Disclaimer - Privacy